Assure (NASDAQ:IONM) Price Target Lowered to $4.00 at Benchmark

Assure (NASDAQ:IONMGet Rating) had its price target trimmed by Benchmark from $8.00 to $4.00 in a report published on Tuesday, The Fly reports.

Separately, Roth Mkm reduced their target price on Assure from $60.00 to $12.00 and set a buy rating for the company in a research report on Wednesday, April 12th.

Assure Price Performance

NASDAQ IONM opened at $1.00 on Tuesday. The company has a 50 day simple moving average of $2.63 and a 200-day simple moving average of $4.09. Assure has a 52-week low of $0.93 and a 52-week high of $113.00. The company has a debt-to-equity ratio of 7.31, a current ratio of 2.58 and a quick ratio of 2.58.

Insider Buying and Selling

In other news, major shareholder Preston T. Parsons sold 7,000 shares of Assure stock in a transaction dated Friday, March 24th. The stock was sold at an average price of $4.11, for a total transaction of $28,770.00. Following the sale, the insider now directly owns 184,125 shares of the company’s stock, valued at $756,753.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Assure news, major shareholder Preston T. Parsons sold 7,000 shares of Assure stock in a transaction that occurred on Friday, March 24th. The stock was sold at an average price of $4.11, for a total value of $28,770.00. Following the completion of the sale, the insider now directly owns 184,125 shares in the company, valued at $756,753.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder Preston T. Parsons sold 6,600 shares of Assure stock in a transaction that occurred on Tuesday, April 4th. The stock was sold at an average price of $4.85, for a total value of $32,010.00. Following the completion of the sale, the insider now owns 177,525 shares of the company’s stock, valued at $860,996.25. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,989 shares of company stock worth $80,976. Company insiders own 40.70% of the company’s stock.

Hedge Funds Weigh In On Assure

An institutional investor recently bought a new position in Assure stock. Empery Asset Management LP bought a new stake in shares of Assure Holdings Corp. (NASDAQ:IONMGet Rating) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 56,264 shares of the company’s stock, valued at approximately $36,000. Empery Asset Management LP owned 0.43% of Assure at the end of the most recent reporting period. 6.57% of the stock is owned by institutional investors.

About Assure

(Get Rating)

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.

Featured Stories

The Fly logo

Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.